TY  - GEN
AU  - Barbier,A J
AU  - Bielefeld,B
AU  - Whiteman,D A H
AU  - Natarajan,M
AU  - Pano,A
AU  - Amato,D A
TI  - The relationship between anti-idursulfase antibody status and safety and efficacy outcomes in attenuated mucopolysaccharidosis II patients aged 5 years and older treated with intravenous idursulfase
SN  - 1096-7206
PY  - 2014///0508
KW  - Administration, Intravenous
KW  - Adolescent
KW  - Adult
KW  - Antibodies
KW  - immunology
KW  - Child
KW  - Child, Preschool
KW  - Enzyme Replacement Therapy
KW  - adverse effects
KW  - Genotype
KW  - Glycoproteins
KW  - genetics
KW  - Glycosaminoglycans
KW  - urine
KW  - Humans
KW  - Iduronate Sulfatase
KW  - administration & dosage
KW  - Liver
KW  - metabolism
KW  - Mucopolysaccharidosis II
KW  - drug therapy
KW  - Organ Size
KW  - Spleen
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article
UR  - https://doi.org/10.1016/j.ymgme.2013.08.002
ER  -